Evaluating a new PET/CT scan for diagnosing epithelial tumors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the diagnostic efficacy of 68Ga-MY6349 PET/CT imaging in patients with tumors of epithelial origin. It employs an autocontrol approach, enrolling 40 patients who will undergo both 68Ga-MY6349 and 68Ga-PSMA/18F-FDG PET/CT scans. The goal is to compare the effectiveness of these imaging techniques in diagnosing, staging, and monitoring tumor recurrence, using pathological findings as the gold standard for assessment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

\- Age ≥ 18 years; Patients with pathologically confirmed tumour and proposed surgical resection/exploration (including primary or recurrent metastatic tumour); Expected survival \> 3 months, as judged by the doctor; Voluntarily sign the informed consent form; willing and able to follow the study protocol

Exclusion Criteria:

\- Persons with a known history of hypersensitivity to 68Ga-MY6349 and 68Ga-PSMA or 18F-FDG and their excipients; Those who cannot tolerate intravenous drug delivery methods (e.g., history of needle and blood sickness); Patients who have received anti-tumour therapy before the examination or neoadjuvant chemotherapy/targeted therapy for tumour reduction after the examination and up to the preoperative period; Pregnant and lactating women; Practitioners who need to be exposed to radioactive conditions for a long time; Serious diseases of heart, kidney, lung, vascular, neurological and psychiatric systems, immunodeficiency diseases and hepatitis/cirrhosis; Have participated in other interventional clinical trials within 1 month prior to screening; Patients undergoing chemotherapy, immunotherapy or molecular targeted therapy; Presence of other conditions that, in the opinion of the investigator, make participation in this study unsuitable.

Where it's running

• Department of Nuclear Medicine,Xijing Hospital, Fourth Military Medical University, Xi'an, China
  Xi'an, Shaanxi, China Recruiting

Study contacts

• Study coordinator: Ying Guo Ying Guo
• Email: guoying01192022@163.com
• Phone: 0086+15991459177

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Iparomlimab/Tuvonralimab with nab-paclitaxel and cisplatin as neoadjuvant therapy for locally advanced cervical cancer

  This trial tests whether adding Iparomlimab/Tuvonralimab to nab-paclitaxel and cisplatin before surgery can shrink locally advanced cervical cancer and safely be given to adult women.

  Recruiting Phase 2 Xijing Hospital · Xi'an, Shaanxi · NCT07876154

• Ofatumumab for drug-refractory Narcolepsy Type 1

  Aims to see if a single dose of ofatumumab helps people with Narcolepsy Type 1 who have not responded to previous treatments.

  Recruiting Phase 1/2 Xijing Hospital · Xi'an, Shaanxi · NCT07871006

• Drug-coated balloons vs drug-eluting stents for immediate slow-flow/no-reflow in STEMI with high thrombus

  This study tests whether using a drug-coated balloon instead of a drug-eluting stent during PCI helps reduce immediate slow-flow or no-reflow in STEMI patients with high thrombus burden.

  Recruiting Xijing Hospital · Xi'an, Shaanxi · NCT07806370

• Transjugular implantation of a leadless pacemaker (Aveir VR) for ventricular pacing

  This study tests whether placing an Aveir VR leadless pacemaker through the neck vein can safely provide ventricular pacing in adults with bradycardia.

  Recruiting Xijing Hospital · Xi'an, Shaanxi · NCT07802119

• Anti-HER2 therapy plus chemotherapy after surgery for HER2-positive stomach cancer

  In people with stage IB-II HER2-positive gastric cancer who have had surgery, this study tests whether adding trastuzumab to standard chemo helps more than chemo alone.

  Recruiting Phase 2 Xijing Hospital · Xi'an, Shaanxi · NCT07788196

• Is XJH05 Ointment Effective for Plaque Psoriasis?

  This study tests whether the XJH05 ointment can help people with plaque psoriasis compare to a calcipotriol ointment.

  Recruiting Xijing Hospital · Xi'an, Shaanxi · NCT07780929

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.